ad image

Nice Match

1 / 14
Vantage Solutions

Vantage Nutrition LLC Acquires ComboCap Inc

Vantage Solutions

PR-M03-23-07Mar 27, 2023
Pluristyx
M&A

Pluristyx, panCELLa, and Implant Therapeutics Announce Definitive Merger Agreement

Pluristyx

PR-M10-22-04Oct 06, 2022
AcuraBio
Acquisition and Rebranding

Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio

AcuraBio

PR-M09-22-01Sep 07, 2022
Rephine
Audit Service Merger

Merger of Rephine with Forum Auditorias & TDV Creates Clear Market Leader in Global GMP Audit Services

Rephine

PR-M07-22-01Jul 06, 2022
ProductLife Group
M&A

ProductLife Group Strengthens Foothold in Northern Europe with Pharma IT Acquisition

ProductLife Group

PR-M06-22-08Jun 30, 2022
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
Column: M&A

Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.

Nigel Walker

Nice Insight

PAO-06-022--NI-12Jun 24, 2022
Novo Holdings A/S
M&A

Novo Holdings Portfolio Company ReViral to be Acquired by Pfizer

Novo Holdings A/S

PR-M04-22-05Apr 07, 2022
Incannex Healthcare Limited
M&A

Incannex to Acquire APIRx Pharmaceuticals USA, LLC

Incannex Healthcare Limited

PR-M03-22-12Mar 24, 2022
Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game
Column: M&A

Why the Big Shifts in Gene Therapy Investments? It’s Late in the Game

Nigel Walker

Nice Insight

PAO-03-022-NI-08Mar 23, 2022
Ginkgo Bioworks
M&A

Ginkgo Bioworks Signs Definitive Agreement to Acquire FGen AG, a Leading Bioengineering Company and Its Proprietary Ultra-High-Throughput Screening Platform

Ginkgo Bioworks

PR-M03-22-05Mar 14, 2022
Vibalogics
CDMO Acquisition

Vibalogics Acquired by Top Global CDMO Recipharm AB

Vibalogics

PR-M02-22-18Feb 18, 2022
Recipharm AB
CDMO Acquisition

Recipharm Acquires Arranta Bio, a CDMO Leader in Advanced Therapy Medicinal Products (ATMPs), to Expand its Biologics Offering in the U.S.

Recipharm AB

PR-M02-22-17Feb 18, 2022
TriRx Pharmaceutical Services
M&A

TriRx Completes Acquisition of Elanco Manufacturing Facility in Speke, United Kingdom

TriRx Pharmaceutical Services

PR-M02-22-06Feb 08, 2022
Samsung Biologics
M&A

Samsung Biologics Reaches Agreement With Biogen to Acquire Full Ownership of Samsung Bioepis

Samsung Biologics

PR-M01-22-21Jan 28, 2022
Enzymaster
M&A

Enzymaster’s Sanming Minhe Acquisition Increases Production Capacity by 50% to Keep Pace with Rapidly Growing Demand

Enzymaster

PR-M01-22-14Jan 20, 2022
ProtaGene
M&A

Analytical Service Leaders in Biopharmaceutical and Gene Therapy Development Unify Operations and Re-brand as ProtaGene

ProtaGene

PR-M01-22-09Jan 12, 2022
TriRx Pharmaceutical Services
New Facility

TriRx Hosted State and Community Leaders to Celebrate Acquisition of Shawnee, Kansas Facility

TriRx Pharmaceutical Services

PR-M07-21-013Aug 11, 2021
TriRx Pharmaceutical Services
Facility Acquisition

TriRx Enters Agreement for the Acquisition of Elanco Animal Health Facilities in Shawnee, Kansas and Speke, United Kingdom

TriRx Pharmaceutical Services

PR-M06-21-019Jun 15, 2021
Jazz Pharmaceuticals
Acquisition

Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc

Jazz Pharmaceuticals

PR-M05-21-005-999May 06, 2021
Grifols
Acquisition

Grifols Reinforces its Innovation Strategy After Completing the Acquisition of GigaGen to Boost a Novel Method to Generate a Wide Range of Immunoglobulins

Grifols

PR-M11-20-045Mar 09, 2021
1 / 14